Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Caraco Pharmaceutical Laboratories, a company that manufactures, develops, markets and distributes generic pharmaceuticals, has reported net sales of $40.39m for the third quarter ended 31 December 2010, compared to $51.99m for the same period in 2009.
Subscribe to our email newsletter
For the third quarter of 2010, the company’s operating loss was $4.99m, compared to $5.07m for the same period in 2009.
Net loss was $3.04m, compared to $3.03m for the same period in 2009.
For the nine months of 2010, the company posted net sales of $268.21m, compared to $178.44m for the same period in 2009.
Caraco Pharma‘s operating loss was $5.86m for the nine month, compared to $8.87m for the same period in 2009.
The company has reported net loss of $3.33m, compared to $5.79m for the same period in 2009.